DnaJC16 inhibitors are a class of chemical compounds designed to specifically target and modulate the activity of the DnaJC16 protein, a member of the DnaJ (Hsp40) co-chaperone family. Proteins in the DnaJ family are known for their role in regulating the function of heat shock proteins (Hsp70), which are involved in a wide range of cellular processes, including protein folding, assembly, translocation, and degradation. DnaJC16, like other DnaJ proteins, is characterized by the presence of a J-domain, which is crucial for its interaction with Hsp70 and the modulation of its activity. DnaJC16 is thought to participate in specific cellular pathways related to protein quality control and stress responses, influencing the stability and function of client proteins. Inhibitors of DnaJC16 are developed to disrupt its interaction with Hsp70 or to interfere with its co-chaperone activity, thereby allowing researchers to study its specific roles in cellular homeostasis and stress management.
The development of DnaJC16 inhibitors involves a detailed analysis of the protein's structure, particularly its J-domain and other regions that are critical for its interaction with Hsp70 and client proteins. Structural biology techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy are utilized to elucidate the three-dimensional structure of DnaJC16. This structural information is essential for identifying key binding sites where inhibitors can interact with DnaJC16 to block its function. Computational methods, including molecular docking and virtual screening, are then employed to identify small molecules that can specifically bind to these critical regions with high affinity, effectively inhibiting DnaJC16's activity. Once potential inhibitors are identified, they undergo synthesis and rigorous in vitro testing to evaluate their binding properties, specificity, and inhibitory potency. These inhibitors are further optimized through iterative cycles of chemical refinement to enhance their effectiveness and stability. The study of DnaJC16 inhibitors provides valuable insights into the role of co-chaperones in cellular stress responses and protein quality control, contributing to a broader understanding of the molecular mechanisms that maintain cellular proteostasis and overall cellular health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to Hsp90 and disrupts its function, leading to the degradation of DNAJC16 and other client proteins, resulting in altered cellular signaling pathways. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
Similar to geldanamycin, radicicol binds to Hsp90 and disrupts its chaperone activity, causing degradation of DNAJC16 and other client proteins. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Binds to Hsp90, blocking its function and promoting degradation of DNAJC16 and other client proteins, which can impact cancer cell growth and survival. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
Acts as a Hsp90 inhibitor by covalently modifying its cysteine residues, disrupting its chaperone function and leading to the degradation of DNAJC16 and other client proteins. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Exhibits inhibitory effects on Hsp90, leading to impaired protein folding and degradation of DNAJC16 and other client proteins involved in cell cycle regulation and signaling pathways. | ||||||
NVP-AUY922 | 747412-49-3 | sc-364551 sc-364551A sc-364551B sc-364551C sc-364551D sc-364551E | 5 mg 25 mg 100 mg 250 mg 1 g 5 g | $150.00 $263.00 $726.00 $1400.00 $2900.00 $11000.00 | 3 | |
Binds to Hsp90 and interferes with its chaperone activity, leading to the degradation of DNAJC16 and other client proteins, which can affect cell survival and proliferation. | ||||||
Ganetespib | 888216-25-9 | sc-364496 sc-364496A | 10 mg 250 mg | $273.00 $1040.00 | ||
Inhibits Hsp90 by binding to its ATP-binding site, causing the degradation of DNAJC16 and other client proteins, potentially impacting the growth and survival of cancer cells. | ||||||